Multidrug-resistant tuberculosis


Only about half of patients with multidrug-resistant TB are cured. Unitaid is investing in developing treatments that are simpler, shorter and less toxic.

Lesotho, March 2017. Botshabelo MDR-TB Hospital. Patient Makara Moabi.
TB is a top priority for Unitaid, including this most recent effort to speed access to better, shorter, and more effective MDR-TB treatments. Image: Graeme Williams / Unitaid

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.